Clopidogrel monotherapy in patients with and without on-treatment high platelet reactivity: a SMART-CHOICE substudy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seung Hun | - |
dc.contributor.author | Lee, Sang Yeub | - |
dc.contributor.author | Chun, Woo Jung | - |
dc.contributor.author | Song, Young Bin | - |
dc.contributor.author | Choi, Seung-Hyuk | - |
dc.contributor.author | Jeong, Jin-Ok | - |
dc.contributor.author | Oh, Seok Kyu | - |
dc.contributor.author | Yun, Kyeong Ho | - |
dc.contributor.author | Koh, Young-Youp | - |
dc.contributor.author | Bae, Jang-Whan | - |
dc.contributor.author | Choi, Jae Woong | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Hahn, Joo-Yong | - |
dc.date.accessioned | 2024-06-10T05:00:25Z | - |
dc.date.available | 2024-06-10T05:00:25Z | - |
dc.date.issued | 2021-12 | - |
dc.identifier.issn | 1774-024X | - |
dc.identifier.issn | 1969-6213 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74081 | - |
dc.description.abstract | Background: Although P2Y(12) inhibitor monotherapy has emerged as a promising alternative for dual anti-platelet therap) (DAPT), there remains concern regarding the safety of clopidogrel monotherapy. Aims: We sought to investigate clinical outcomes of clopidogrel monotherapy in patients with and without on-treatment high platelet reactivity (HPR). Methods: In the SMART-CHOICE study, three-month DAPT followed by P2Y(12) inhibitor monotherapy was compared with 12-month DAPT in patients undergoing percutaneous coronary intervention. A platelet function test was performed for 833 patients with clopidogrel-based therapy. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE: a composite of all-cause death, myocardial infarction, or stroke) at 12 months. Results: Overall, 108 (13.0%) patients had HPR on clopidogrel. Patients with HPR had a significantly higher rate of MACCE than patients without HPR (8.7% vs 1.5%, adjusted HR 3.036, 95% CI: 1.060-8.693, p=0.038). The treatment effect of clopidogrel monotherapy for the 12-month MACCE was not significantly different compared with DAPT among patients with HPR (8.0% vs 9.4%, adjusted HR 0.718, 95% CI: 0.189-2.737, p=0.628) and without HPR (2.2% vs 0.9%, adjusted HR 2.587, 95% CI: 0.684-9.779, p=0.161; adjusted p for interaction=0.170). Conclusions: Clopidogrel monotherapy showed treatment effects comparable to DAPT for MACCE in patients with or without HPR. However, HPR was significantly associated with an increased risk of MACCE in clopidogrel-treated patients regardless of maintenance of aspirin. Clinical Trial Registration: Comparison Between P2Y(12) Antagonist Monotherapy and Dual Antiplatelet Therapy After DES (SMART-CHOICE). | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | EUROPA EDITION | - |
dc.title | Clopidogrel monotherapy in patients with and without on-treatment high platelet reactivity: a SMART-CHOICE substudy | - |
dc.type | Article | - |
dc.identifier.doi | 10.4244/EIJ-D-21-00223 | - |
dc.identifier.bibliographicCitation | EUROINTERVENTION, v.17, no.11, pp E888 - E897 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000737952900008 | - |
dc.identifier.scopusid | 2-s2.0-85122084249 | - |
dc.citation.endPage | E897 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | E888 | - |
dc.citation.title | EUROINTERVENTION | - |
dc.citation.volume | 17 | - |
dc.type.docType | Article | - |
dc.publisher.location | 프랑스 | - |
dc.subject.keywordAuthor | adjunctive pharmacotherapy | - |
dc.subject.keywordAuthor | clinical research | - |
dc.subject.keywordAuthor | drug-eluting stent | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | DUAL ANTIPLATELET THERAPY | - |
dc.subject.keywordPlus | P2Y12 INHIBITOR MONOTHERAPY | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | CARDIOVASCULAR EVENTS | - |
dc.subject.keywordPlus | FOCUSED UPDATE | - |
dc.subject.keywordPlus | OPEN-LABEL | - |
dc.subject.keywordPlus | IMPLANTATION | - |
dc.subject.keywordPlus | ASPIRIN | - |
dc.subject.keywordPlus | RESPONSIVENESS | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.